We use cookies to collect information, and enable our website to work properly. Please tell us whether you accept cookies by clicking the button below. If you decide not to accept cookies, our site may not work as expected and some information may not be available.

Click here for more information on cookies, including how to remove them.

MEMBER LOGIN

About GenQA Why Us Meet the team Work with us Accreditation Governance Going Green Testimonials

Our EQAs Calendar Updates for 2025 Pilot EQAs EQA Benefits Our fees Performance Monitoring Pre-2018

About GENie WGS/WES Proportionate variant analysis Genomic laboratory videos Tissue assessment (Tissue-i) Variant classification (BRCA-HRR) Variant classification (germline SNV/CNV) Variant nomenclature (HGVS/ISCN) COVID-19 Care Home Swabbing

Annual Report 2024 Education & Training FAQs GenQA webinars Glossary News Publications Resource card: Variants Sample donation UK NEQAS

MENU menu

News

New EQA for 2020: Prediction of 5-Fluorouracil Toxicity (Testing of DPYD variants)

14 July 2020

EQA Updates

GenQA are delighted to open registration for our latest new EQA. This pilot EQA is open for all laboratories offering DPYD testing to predict toxicity in patients treated with 5-fluorouracil (5-FU) based chemotherapy.

For full details see https://www.genqa.org/eqa/687

Three DNA samples will be provided for analysis in October 2020, with four weeks for analysis.

If you are interested in participating in this EQA but are not yet a member of GenQA, then please register to join GenQA.

<< BACK